Cindy Ippoliti

6.0k total citations · 1 hit paper
81 papers, 4.4k citations indexed

About

Cindy Ippoliti is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cindy Ippoliti has authored 81 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 28 papers in Oncology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cindy Ippoliti's work include Hematopoietic Stem Cell Transplantation (41 papers), Polyomavirus and related diseases (12 papers) and Acute Myeloid Leukemia Research (12 papers). Cindy Ippoliti is often cited by papers focused on Hematopoietic Stem Cell Transplantation (41 papers), Polyomavirus and related diseases (12 papers) and Acute Myeloid Leukemia Research (12 papers). Cindy Ippoliti collaborates with scholars based in United States, United Kingdom and China. Cindy Ippoliti's co-authors include Sergio Giralt, Richard E. Champlin, Issa F. Khouri, Börje S. Andersson, Donna Przepiorka, James Gajewski, Michèle L. Donato, Paolo Anderlini, Marcos de Lima and Daniel R. Couriel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Cindy Ippoliti

78 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

1998 738 citations Issa F. Khouri, Michael J. Keating et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cindy Ippoliti United States	31	2.9k	1.3k	1.2k	719	608	81	4.4k
Gary Schoch United States	31	3.2k 1.1×	979 0.8×	1.1k 0.9×	775 1.1×	527 0.9×	63	4.9k
Klingemann Hg Canada	20	4.4k 1.5×	1.7k 1.3×	1.4k 1.1×	994 1.4×	903 1.5×	41	5.5k
Daniel Weisdorf United States	12	4.0k 1.4×	1.6k 1.2×	1.1k 0.9×	931 1.3×	601 1.0×	21	4.7k
Mathieu Kuentz France	34	2.2k 0.8×	957 0.7×	977 0.8×	522 0.7×	631 1.0×	97	4.0k
Voravit Ratanatharathorn United States	29	2.0k 0.7×	1.1k 0.9×	857 0.7×	432 0.6×	369 0.6×	140	3.6k
Rainer Schwerdtfeger Germany	43	4.3k 1.5×	1.3k 1.0×	1.4k 1.1×	1.2k 1.6×	1.2k 2.0×	126	6.0k
Javier Bolaños‐Meade United States	32	3.0k 1.0×	1.4k 1.1×	1.0k 0.9×	584 0.8×	892 1.5×	119	4.2k
Anna Maria Raiola Italy	38	2.4k 0.8×	910 0.7×	1.2k 1.0×	518 0.7×	634 1.0×	118	3.8k
Seok‐Goo Cho South Korea	32	2.0k 0.7×	1.2k 1.0×	1.2k 1.0×	569 0.8×	1.1k 1.9×	330	4.5k
Je‐Hwan Lee South Korea	40	3.0k 1.0×	972 0.7×	1.1k 0.9×	776 1.1×	821 1.4×	309	5.0k

Countries citing papers authored by Cindy Ippoliti

Since Specialization

Citations

This map shows the geographic impact of Cindy Ippoliti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Ippoliti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Ippoliti more than expected).

Fields of papers citing papers by Cindy Ippoliti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Ippoliti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Ippoliti. The network helps show where Cindy Ippoliti may publish in the future.

Co-authorship network of co-authors of Cindy Ippoliti

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Ippoliti. A scholar is included among the top collaborators of Cindy Ippoliti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Ippoliti. Cindy Ippoliti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campbell, Peter M., Melissa Beauchemin, Elena B. Elkin, et al.. (2024). Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs. JCO Oncology Practice. 21(4). 544–551.

Martínez-Momblán, Maria-Antonia, et al.. (2009). Factores de riesgo cardiovascular entre pacientes con síndrome de Cushing, curados y no curados con respecto a un grupo control. 31–34. 1 indexed citations

Couriel, Daniel R., Rima M. Saliba, Marcos de Lima, et al.. (2009). A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 15(12). 1555–1562. 84 indexed citations

Lewis, Russell E., et al.. (2007). Caspofungin as Primary Antifungal Prophylaxis in Stem Cell Transplant Recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1644–1650. 49 indexed citations

Kebriaei, Partow, Rima M. Saliba, Cindy Ippoliti, et al.. (2006). Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia. Bone Marrow Transplantation. 38(3). 203–209. 28 indexed citations

Anderlini, Paolo, Rima M. Saliba, Sandra Acholonu, et al.. (2005). Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplantation. 35(10). 943–951. 86 indexed citations

Couriel, Daniel R., Peter F. Thall, Marcos de Lima, et al.. (2005). Phase II/III Randomized Study Comparing Two Different Tacrolimus Blood Levels for the Prevention of Graft-Versus-Host Disease (GVHD).. Blood. 106(11). 142–142. 4 indexed citations

Donato, Michèle L., Ana Aleman, Richard E. Champlin, et al.. (2003). High-Dose Topotecan, Melphalan and Cyclophosphamide (TMC) with Stem Cell Support: a New Regimen for the Treatment of Multiple Myeloma. Leukemia & lymphoma. 45(4). 755–759. 20 indexed citations

Wong, Raymond, Marcos de Lima, Sergio Giralt, et al.. (2003). Tacrolimus‐associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 122(1). 128–134. 126 indexed citations

10.

Khouri, Issa F., Mark F. Munsell, Susan O’Brien, et al.. (2000). Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL): The case for early intervention. Blood. 96. 13 indexed citations

11.

Kornblau, Steven M., Al B. Benson, Robert B. Catalano, et al.. (2000). Management of Cancer Treatment–Related Diarrhea. Journal of Pain and Symptom Management. 19(2). 118–129. 69 indexed citations

12.

Przepiorka, Donna, Nancy A. Kernan, Cindy Ippoliti, et al.. (2000). Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood. 95(1). 83–89. 199 indexed citations

13.

Ippoliti, Cindy, et al.. (1998). Dexrazoxane: A New Cardioprotective Agent. Journal of Pharmacy Technology. 14(5). 182–190.

14.

Ippoliti, Cindy, et al.. (1997). Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. Bone Marrow Transplantation. 19(8). 845–847. 4 indexed citations

15.

Ippoliti, Cindy, R. Champlin, Donna Przepiorka, et al.. (1997). Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.. Journal of Clinical Oncology. 15(11). 3350–3354. 32 indexed citations

16.

Przepiorka, Donna, Paolo Anderlini, Cindy Ippoliti, et al.. (1997). Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplantation. 19(5). 455–460. 66 indexed citations

17.

Khouri, Issa F., Cindy Ippoliti, James Gajewski, Donna Przepiorka, & R. Champlin. (1996). Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin. American Journal of Hematology. 52(4). 313–315. 11 indexed citations

18.

Ippoliti, Cindy, Donna Przepiorka, Rakesh Mehra, et al.. (1995). Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 46(6). 811–815. 30 indexed citations

19.

Miller, Lisa, Sonja W. Chandler, & Cindy Ippoliti. (1994). Treatment of Cyclophosphamide-Induced Hemorrhagic Cystitis with Prostaglandins. Annals of Pharmacotherapy. 28(5). 590–594. 20 indexed citations

20.

Przepiorka, Donna, et al.. (1994). Blood tacrolimus concentration unchanged by plasmapheresis.. PubMed. 51(13). 1708–1708. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact